Skip to content

Cerus CERS Long-Term Debt

Long-Term Debt at other companies

Haemonetics logo
HaemoneticsHAE
$1.22B+32.4%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$802.9M-33.1%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$2.69B+7.5%
ADMA Biologics logo
ADMA BiologicsADMA
$193.58M
Paysign logo
PaysignPAYS
$4.55M-41.7%

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:SecuredLongTermDebt.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's long-term debt?
Cerus (CERS) reported long-term debt of $32.43M in Q1 2026.
How has Cerus's long-term debt changed year-over-year?
Cerus's long-term debt decreased by 50.0% year-over-year, from $64.88M to $32.43M.
What is the long-term trend for Cerus's long-term debt?
Over 5 years (2020 to 2025), Cerus's long-term debt has grown at a 0.5% compound annual growth rate (CAGR), from $39.59M to $40.55M.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.